Heart Field-Specific Progenitor Cell Induction via Bmp and Wnt Signaling

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods lack effective strategies for selectively inducing and isolating first and second heart field populations from pluripotent stem cells, which are crucial for understanding heart formation and developing therapeutic strategies for heart diseases.

Innovation Solution

The method involves using Bmp and Wnt signaling pathways, along with the cell surface protein Cxcr4, to specify and isolate first and second heart field populations in pluripotent stem cells, enabling the generation of heart field-specific progenitors for modeling and treating heart field/chamber-specific diseases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If pluripotent stem cells are differentiated into heart field populations, then heart field-specific progenitors can be generated for disease modeling and therapy, but the current methods lack effective strategies for selective induction and isolation of specific heart field populations

Engineering Contradiction:

Improveselective induction of heart field-specific progenitorsVSAvoidmethod complexity

Core Design Contradiction:

Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by utilizing different signaling pathway activators (Bmp for FHF, Wnt for SHF) and modulating signaling pathway activity levels to selectively induce specific heart field populations. By changing the signaling parameters (which pathway to activate and at what intensity), the method achieves precise control over heart field specification without requiring complex multi-step protocols

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent uses signaling pathway activators (Bmp and Wnt proteins, along with their respective inhibitors) as intermediary substances to mediate the differentiation process. These activators serve as controllable intermediaries that translate external control signals into specific heart field fates, simplifying the induction process while maintaining precision

Inventive Principle:

Principle #24Intermediary (Mediator)

2Manufacturing precision

If heart field populations are generated from pluripotent stem cells, then therapeutic strategies for heart diseases can be developed, but effective isolation strategies for specific heart field populations are lacking

Engineering Contradiction:

Improveisolation of heart field populationsVSAvoidisolation process complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs fluorescent protein expression as a 'color change' marker system to visually distinguish and isolate different heart field populations. By introducing fluorescent markers that are selectively expressed in FHF or SHF cells, the method enables straightforward identification and isolation procedures, transforming a complex isolation problem into a simple visual sorting task

Inventive Principle:

Principle #32Color changes

Solution Approach 2:

The patent replaces complex mechanical isolation systems with molecular and cellular mechanisms. Instead of relying on physical separation methods, the invention uses differential expression of surface markers and signaling pathway responsiveness as the basis for isolation, substituting mechanical complexity with biological specificity

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If Bmp and Wnt signaling pathways are used to specify heart fields, then selective induction of FHF and SHF can be achieved, but the pathways must be differentially regulated which adds complexity

Engineering Contradiction:

Improvespecification of heart fieldsVSAvoidpathway regulation complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent segments the heart field specification process into distinct, controllable modules: Bmp signaling for FHF specification and Wnt signaling for SHF specification. By dividing the complex regulation into separate pathway modules that can be independently controlled, the method achieves precise specification while managing complexity through modular design

Inventive Principle:

Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the selective induction of heart field-specific progenitors, providing insights into heart formation and enabling the development of PSC-based therapeutic strategies for heart diseases, such as congenital heart defects.

Implementation Method 1

Bmp signaling specifies FHF cells and SHF cells via the Bmp/Smad pathway

Methodology Applied

Scientific EffectBmp/Smad signaling pathway:

Implementation Method 2

Wnt signaling, respectively

Methodology Applied

Scientific EffectWnt signaling:

Implementation Method 3

the method further comprises providing a Wnt pathway activator, comprising a glycogen synthesis kinase 3 (Gsk3) inhibitor

Methodology Applied

Scientific EffectWnt pathway activation:

Data Source

PatentUS20220073883A1Compositions and methods for generation of heart field-specific progenitor cells

Publication Date: 2022.03.10 JOHNS HOPKINS UNIVERSITY

AI summary

The present invention relates to compositions and methods for producing, identifying and isolating heart progenitor cells.